EGM
SKYE icon

Engineers Gate Manager’s Skye Bioscience SKYE Stock Holding History

Engineers Gate Manager’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4K Sell
20,194
-2,944
-13% -$2.4K ﹤0.01% 2131
2025
Q4 		$17.3K Buy
+23,138
New +$33.8K ﹤0.01% 2034

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Engineers Gate Manager's SKYE Position: Q1 2026 in Review

Engineers Gate Manager reduced its Skye Bioscience (SKYE) stake by 13% in Q1 2026, selling an estimated $2.4K and leaving 20,194 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Engineers Gate Manager first reported a position in SKYE in Q4 2025 and has held it in 2 quarters since. The position peaked at $17.3K in Q4 2025. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • Engineers Gate Manager held 20,194 shares of Skye Bioscience worth $12.4K as of Q1 2026.
  • Engineers Gate Manager sold 2,944 Skye Bioscience shares in Q1 2026, an estimated $2.4K.
  • Skye Bioscience made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #2131 holding.
  • Engineers Gate Manager first reported a position in Skye Bioscience in Q4 2025 and has held it in 2 quarters since.
  • Engineers Gate Manager's Skye Bioscience position peaked at $17.3K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.